Wet Form of Age-related Macular Degeneration – Selected Aspects of Therapy.
str. 77 – 81
Autorzy: Małgorzata Wichrowska, Wojciech Suda, Jarosław Kocięcki.
Katedra Okulistyki i Klinika Okulistyczna Uniwersytetu Medycznego im. K. Marcinkowskiego w Poznaniu
Kierownik Kliniki: prof. dr hab. n. med. Jarosław Kocięcki
Currently, the gold standard of therapy for patients with the wet form of age-related macular degeneration is the intravitreal injection of anti-vascular endothelial growth factor preparations. There is no doubt that the introduction of anti-vascular endothelial growth factor preparations has made it possible for many patients to maintain a useful visual acuity, influencing their quality of life improvement. Treatment of patients with this disease remains, however, a chronic process, which often takes many years, with an unpredictable duration and end-point. The authors of the study reviewed the literature in search of an answer to the question: where are we in the treatment of a wet form of age-related macular degeneration and whether we have achieved therapeutic success; they also share their own clinical experience.